SCHRODER INVESTMENT MANAGEMENT GROUP
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1086619
London, X0
Position in RYTM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$11,451,687
+$9,629,627 QoQ
Shares Held
131,674
+629.8% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. RYTM ranks #15 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
163,898 | $73,187,011 | |
| 2 | TECH |
BIO-TECHNE Corp
|
1,197,214 | $62,566,403 | |
| 3 | EXEL |
Exelixis, Inc.
|
525,533 | $22,540,109 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
66,662 | $22,056,454 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
648,827 | $21,722,727 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
39,852 | $20,861,326 | |
| 7 | INSM |
INSMED Inc
|
119,958 | $19,615,531 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
484,381 | $19,486,647 |
All Filings in RYTM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,451,687 | 131,674 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $1,822,060 | 18,042 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,113,281 | 17,618 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $933,225 | 17,618 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||